Cosmetic Surgery Products Market Size, Share, Opportunities, And Trends By Product Type (Cosmetic Surgery Implants, Breast Implants, Chin & Cheek Implants, Injectables, Botulinum Toxin, Soft Tissue Fillers, Dermal Fillers, Absorbable Fillers, Non-Absorbable Fillers, Cosmetic Surgery Lasers, Ablative Laser, Non-Ablative Laser, Microdermabrators, Liposuction Equipment, Cosmetic Surgery Services), By Application (Face, Upper Body, Breasts, Stomach, Lower Body), By End-user (Hospitals, Ambulatory Surgical Centers, Clinics, Universities And Research Centers, Homecare Settings), And By Geography - Forecasts From 2024 To 2029

  • Published : Mar 2024
  • Report Code : KSI061616778
  • Pages : 148

The cosmetic surgery product market is expected to witness significant growth during the forecasted period.

The market for products used in cosmetic surgery includes a broad spectrum of items intended to improve or modify physical appearance through surgical procedures. The implants, injectables, tools, and accessories used in facelifts, rhinoplasty, liposuction, and other cosmetic procedures are included in this market.

Improvement in surgical methods, rising consumer acceptability and awareness of cosmetic treatments, and rising levels of disposable income globally are some of the major drivers propelling the cosmetic surgery product market growth. Technological advancements like minimally invasive surgeries and 3D imaging for surgical planning are also boosting market growth.

The market is extremely competitive, and to hold onto their market shares, major businesses must constantly innovate. Players in the industry continue to face major difficulties from regulatory considerations and safety concerns around cosmetic operations and products. Still, with the growing need for aesthetic improvements and the creation of safer and more efficient products, the market for cosmetic surgery products is anticipated to keep expanding in the years to come.

Market Drivers

  • Increased demand for aesthetic products is expected to increase and drive the cosmetic surgery product market.

The increasing demand for aesthetic procedures is propelled by evolving societal norms, where appearance holds significant value. Advances in cosmetic surgery techniques and technology offer safer, more precise procedures with reduced recovery times, appealing to a broader demographic. Additionally, the aging population seeks anti-aging solutions, driving the demand for procedures like facelifts and dermal fillers. Social media's pervasive influence further amplifies beauty ideals, encouraging individuals to pursue cosmetic enhancements to align with digital standards. As awareness grows and stigma diminishes, more people are opting for personalized treatments, contributing to the steady rise in aesthetic procedure demand globally.

In 2022, Members of AAFPRS report a sharp increase in the overall number of non-surgical and surgical facial plastic surgery procedures performed. Plastic surgeons performed an average of 600 more treatments in 2020 compared to the 1.4 million surgical and non-surgical procedures.

Additionally, during the course of the past year, 83 percent of AAFPRS doctors reported an increase in bookings (up from 70 percent in 2020). During this boom, the most prevalent procedures were surgical procedures (rhinoplasty, facelift, blepharoplasty), but there was also an increase in demand for non-surgical treatments.

  • Technological advancements in cosmetic surgery products are expected to boost the market.

The market for products used in cosmetic surgery has seen a technological revolution that has improved patient results, safety, and precision. Modern tissue sculpting tools, less invasive surgical methods, 3D imaging for preoperative planning, robotic support, and other innovations have decreased recovery times, minimized scarring, and increased patient satisfaction.

Moreover, treatment personalization and predictive analysis have been enhanced by the use of AI and machine learning algorithms in cosmetic surgery software. Furthermore, the creation of biocompatible materials for dermal fillers and implants has extended their lifespan and decreased the possibility of negative reactions, pushing the limits of aesthetic improvement while putting patient safety first.

According to NCBI in 2022, Numerous innovative robotic systems, including MicroSurge, ViaCath, SurgiBottm, SPORTtm, MASTER, and SPIDER, are being developed for minimally invasive applications. Still, there aren't many systems whose primary goal is to improve microsurgery performance. The physical limitations of human operators in the absence of robotic support are becoming increasingly apparent as microsurgery advances toward super microsurgery and cannot be made up for by increased magnification. The requirement for minimally invasive access to the surgical site is becoming less critical, while complete tremor eradication and motion scaling are becoming more crucial. In particular, the utmost level of precision is needed for increasingly common procedures such as lymph-venous anastomosis and super-thin free flaps.

  • The growing aging population is also expected to drive the cosmetic surgery product market.

The market for cosmetic surgery products is heavily influenced by the aging population and growing worries about age-related problems, including wrinkles and sagging skin. Anti-aging operations like facelifts, dermal fillers, and Botox injections are becoming more and more popular as people look to keep a young appearance and boost their confidence.

This generational trend drives market expansion together with improvements in cosmetic surgery methods and increased disposable budgets. Further encouraging people, especially older adults, to consider cosmetic modifications is the societal emphasis on beauty standards, which is further reinforced by social media. This has led to an increase in the market for cosmetic surgery products.

According to WHO 2022 data, globally, people are living longer, with one in six people expected to be 60 years or older by 2030. This number is expected to double to 1.4 billion by 2050, and between 2020 and 2050, the number of people 80 years or older will triple to reach 426 million. This trend is expected to continue as the number of older people in the global population continues to rise.

Asia Pacific region is projected to substantial growth.

The market for products used in cosmetic surgery is expanding significantly in the Asia Pacific area due to several causes. Demand is being driven by rising disposable incomes as well as growing acceptability and knowledge of aesthetic operations. Leading this trend are nations like South Korea and Japan, which are renowned for their beauty-focused cultures and have significant demand for cutting-edge cosmetic operations and products. Additionally, consumers' interest in cosmetic modifications is growing throughout the region due to the influence of social media and celebrity endorsements. The availability of qualified professionals and advancements in healthcare infrastructure are also fueling the market's growth in Asia Pacific.

Through a strategic alliance with Changzhou Institute of Medical Materials (CIMM), Vitalorga joins the Chinese market for medical aesthetic devices. The partnership combines CIMM's 37-year history of local Chinese manufacturing with Vitalorga's European technology and safety requirements. The Chinese market for luxury aesthetic medicine was estimated to be worth $62 billion (400 billion RMB) during the course of the next five years, with the medical aesthetic device sector in China valued at USD 372.04 million in 2020. China would thereafter be the biggest participant in this market globally.

Market Restraints

  • Growing consumer expectations pose a significant challenge for the cosmetic surgery product market.

Manufacturers and practitioners are faced with the challenge of satisfying growing consumer expectations while maintaining safety standards in the face of the cosmetic surgery product industry. Finding a balance between innovation and maintaining the highest priority for patient care. It's also critical to address pricing and accessibility issues to serve a variety of groups. In addition, managing ethical issues related to self-esteem and body image, as well as negotiating legal frameworks, are constant obstacles. To establish credibility and trust, advertising must embrace transparency and encourage reasonable expectations. In the end, for the industry to prosper in the face of competition and shifting consumer tastes, it must constantly adjust to societal changes and technological breakthroughs.

Market Developments

  • October 2023- Positive topline findings from two pivotal Phase 3 clinical studies assessing E BoNT/E for the treatment of moderate to severe glabellar lines (M21-500 and M21-508) were released by Allergan Aesthetics. Phase 3 multicenter randomized double-blind placebo-controlled studies assessed the safety and effectiveness of BoNT/E versus placebo in 947 adult participants from the US, Canada, and Europe who had moderate to severe glabellar lines between their eyebrows.
  • May 2022- Leading provider of medical aesthetics systems and solutions, Cynosure, LLC, announced a $60 million fresh investment from principal investor Clayton, Dubilier & Rice. The additional funding bolsters the company's intentions to keep making investments ahead of rapid expansion to provide novel products to the market and offer its clients all-inclusive treatment programs that have the best possible clinical outcomes for patients. Sales at Cynosure, which creates, produces, and distributes medical aesthetic treatment systems and supplies for dermatologists, plastic surgeons, medical spas, and other healthcare professionals, increased by more than 45% in 2021 and more than 30% in the first quarter of 2022 due to robust expansion in every region.


  • By Product Type
    • Cosmetic Surgery Implants
    • Breast Implants
    • Chin & Cheek Implants
    • Injectables
    • Botulinum Toxin
    • Soft Tissue Fillers
    • Dermal Fillers
    • Absorbable Fillers
    • Non-Absorbable Fillers
    • Cosmetic Surgery Lasers
    • Ablative Laser
    • Non-Ablative Laser
    • Microdermabrators
    • Liposuction Equipment
    • Cosmetic Surgery Services
  • By Application
    • Face
    • Upper Body
    • Breasts
    • Stomach
    • Lower Body
  • By End-user
    • Hospitals
    • Ambulatory Surgical Centers
    • Clinics
    • Universities and Research Centers
    • Homecare Settings
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • United Kingdom
      • Germany
      • France
      • Italy
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Taiwan
      • Thailand
      • Indonesia
      • Others


1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

1.8. Key Benefits to the Stakeholder


2.1. Research Design

2.2. Research Processes


3.1. Key Findings

3.2. Analyst View


4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View


5.1. Introduction

5.2. Cosmetic Surgery Implants

5.2.1. Market Trends and Opportunities

5.2.2. Growth Prospects

5.3. Breast Implants

5.3.1. Market Trends and Opportunities

5.3.2. Growth Prospects

5.4. Chin & Cheek Implants

5.4.1. Market Trends and Opportunities

5.4.2. Growth Prospects

5.5. Injectables

5.5.1. Market Trends and Opportunities

5.5.2. Growth Prospects

5.6. Botulinum Toxin

5.6.1. Market Trends and Opportunities

5.6.2. Growth Prospects

5.7. Soft Tissue Fillers

5.7.1. Market Trends and Opportunities

5.7.2. Growth Prospects

5.8. Dermal Fillers

5.8.1. Market Trends and Opportunities

5.8.2. Growth Prospects

5.9. Absorbable Fillers

5.9.1. Market Trends and Opportunities

5.9.2. Growth Prospects

5.10. Non-Absorbable Fillers

5.10.1. Market Trends and Opportunities

5.10.2. Growth Prospects

5.11. Cosmetic Surgery Lasers

5.11.1. Market Trends and Opportunities

5.11.2. Growth Prospects

5.12. Ablative Laser

5.12.1. Market Trends and Opportunities

5.12.2. Growth Prospects

5.13. Non-Ablative Laser

5.13.1. Market Trends and Opportunities

5.13.2. Growth Prospects

5.14. Microdermabrators

5.14.1. Market Trends and Opportunities

5.14.2. Growth Prospects

5.15. Liposuction Equipment

5.15.1. Market Trends and Opportunities

5.15.2. Growth Prospects

5.16. Cosmetic Surgery Services

5.16.1. Market Trends and Opportunities

5.16.2. Growth Prospects


6.1. Introduction

6.2. Face

6.2.1. Market Trends and Opportunities

6.2.2. Growth Prospects

6.3. Upper Body

6.3.1. Market Trends and Opportunities

6.3.2. Growth Prospects

6.4. Breasts

6.4.1. Market Trends and Opportunities

6.4.2. Growth Prospects

6.4.1. Hands Market Trends and Opportunities

6.4.2. Growth Prospects

6.5. Stomach

6.5.1. Market Trends and Opportunities

6.5.2. Growth Prospects

6.6. Lower Body

6.6.1. Market Trends and Opportunities

6.6.2. Growth Prospects


7.1. Introduction

7.2. Hospitals

7.3. Ambulatory Surgical Centers

7.4. Clinics

7.5. Universities and Research Centers

7.6. Homecare Settings

7.6.1. Market Trends and Opportunities

7.6.2. Growth Prospects


8.1. Introduction

8.2. North America

8.2.1. By Animal Type

8.2.2. By Technology

8.2.3. By Application 

8.2.4. By Country United States Market Trends and Opportunities Growth Prospects Canada Market Trends and Opportunities Growth Prospects Mexico Market Trends and Opportunities Growth Prospects

8.3. South America

8.3.1. By Animal Type

8.3.2. By Technology

8.3.3. By Application 

8.3.4. By Country Brazil Market Trends and Opportunities Growth Prospects Argentina Market Trends and Opportunities Growth Prospects Others Market Trends and Opportunities Growth Prospects

8.4. Europe

8.4.1. By Animal Type

8.4.2. By Technology

8.4.3. By Application 

8.4.4. By Country United Kingdom Market Trends and Opportunities Growth Prospects Germany Market Trends and Opportunities Growth Prospects France Market Trends and Opportunities Growth Prospects Italy Market Trends and Opportunities Growth Prospects Spain Market Trends and Opportunities Growth Prospects Others Market Trends and Opportunities Growth Prospects

8.5. Middle East and Africa

8.5.1. By Animal Type

8.5.2. By Technology

8.5.3. By Application 

8.5.4. By Country Saudi Arabia Market Trends and Opportunities Growth Prospects UAE Market Trends and Opportunities Growth Prospects Others Market Trends and Opportunities Growth Prospects

8.6. Asia Pacific

8.6.1. By Animal Type

8.6.2. By Technology

8.6.3. By Application 

8.6.4. By Country Japan Market Trends and Opportunities Growth Prospects China Market Trends and Opportunities Growth Prospects India Market Trends and Opportunities Growth Prospects South Korea Market Trends and Opportunities Growth Prospects Taiwan Market Trends and Opportunities Growth Prospects Thailand Market Trends and Opportunities Growth Prospects Indonesia Market Trends and Opportunities Growth Prospects Others Market Trends and Opportunities Growth Prospects


9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard


10.1. Johnson & Johnson Services 

10.2. Allergan 

10.3. Candela Corp 

10.4. Lumenis Ltd.     

10.5. Cutera Inc

10.6. Palomar Medical    

10.7. Iridex Corp

10.8. DermaMed Pharmaceutical Inc

10.9. Medtronic plc

Johnson & Johnson Services 


Candela Corp 

Lumenis Ltd.     

Cutera Inc

Palomar Medical    

Iridex Corp

DermaMed Pharmaceutical Inc

Medtronic plc